Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort^® MedBot^®"), one of the leading medical robot enterprises in China, attended 4th China Digital Clinical Medicine Application Technology Conference, 5th Shandong Digital Medicine Academic Conference and 1st Oriental Precision Medicine Summit Forum. The well-known domestic academicians and experts were warmly invited to give lectures and conduct academic exchanges at the conferences. It is hoped that the discussion about digital technology in the experimental technology, basic application and research and new clinical technologies will improve the research level and medical quality, enhance the scientific research cooperation and exchanges in various regions, and then promote the overall improvement of new technologies integrating the digital technology with the medical clinical services.

Prof. Haining Sunand Prof. Ming Xu from the 960^th Hospital were specially invited to chair the academic special session of MicroPort^® MedBot^®. Prof. Haining Zhangfrom the Affiliated Hospital of Qingdao University gave a wonderful keynote speech and shared his valuable experience of Honghu Orthopedic Surgical Robot in clinical application.

During the conferences, the booth of MicroPort^® MedBot^® also attracted many participating experts to stop and learn about the total solution of intelligent surgery. We expect more professionals to know and understand MicroPort^® MedBot^® through the conferences and exhibition, and look forward to the future exchanges and cooperation.

The research and development project launched in 2014, by MicroPort^® MedBot^® Group has covered “Five Golden Solutions", including Laparoscopic solution, Orthopedic solution, Panvascular solution, Trans-Natural Orifice solution and Percutaneous Surgical Solution. The Group is committed to meeting the peak demand for robotic surgery. By integrating the cutting-edge research and robot ontology, control algorithms, electrical engineering, image-based navigation and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the maturity and development of robotic surgery, and shape the era of super intelligent surgery.

Mr. Yu Liu , Chief Commercial Officer of MicroPort^® MedBot^®, said: "We are very proud to be unveiled at the conferences and won recognition from so many experts. Thanks to all the experts for the joint witness of the Chinese-developed surgical robots in China, more experts and scholars in the surgical fields can fully understand the technology of robot-assisted micro-invasive surgeries. We look forward to further communication, learning and cooperation with the surgical robot experts domestic and abroad in the future. We will put their ideas and technologies in clinical application into our new generation robots of MicroPort^® MedBot^® to benefit more patients!”